Literature DB >> 20026430

Polymyositis, dermatomyositis and malignancy: a further intriguing link.

S Zampieri1, M Valente, N Adami, D Biral, A Ghirardello, M E Rampudda, M Vecchiato, G Sarzo, S Corbianco, H Kern, U Carraro, F Bassetto, S Merigliano, A Doria.   

Abstract

The association between malignancy and autoimmune myositis has been largely described and confirmed by numerous epidemiological studies. The temporal relationship between the two pathologic conditions can vary: malignancy may occur before, at the same time or following the diagnosis of myositis. Beside these observations, the molecular mechanisms underlying this association are still unknown, even though it has been demonstrated a possible antigenic similarity between regenerating myoblasts and some cancer cell populations. To better identify peculiar histopathologic features common to cancer and myositis, we screened muscle biopsies from patients affected with polymyositis, dermatomyositis, myositis in association to cancer, and from patients affected with newly diagnosed cancer, but without myositis. Similarly to the histopatologic features that were observed in the muscle from myositis patients, especially in those with cancer associated myositis, in patients affected with malignancy at the clinical onset of disease we observed early sign of myopathy, characterized by internally nucleated and regenerating myofibers, most of them expressing the neural cell adhesion molecule. The hypothesis that in a particular subset of individuals genetically predisposed to autoimmunity, an initial subclinical tumor-induced myopathy may result in an autoimmune myositis, represents a further intriguing link behind the association of these two conditions. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20026430     DOI: 10.1016/j.autrev.2009.12.005

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  38 in total

1.  CIR-Myo News: Proceedings of the 2014 Spring Padua Muscle Days: Terme Euganee and Padova (Italy), April 3-5, 2014.

Authors: 
Journal:  Eur J Transl Myol       Date:  2014-03-27

2.  Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.

Authors:  Shir Azrielant; Shmuel Tiosano; Abdulla Watad; Naim Mahroum; Aaron Whitby; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

Review 3.  Dermatomyositis and colorectal cancer: a systematic review.

Authors:  Ioannis D Gkegkes; Evelyn E Minis; Christos Iavazzo
Journal:  Ir J Med Sci       Date:  2017-11-22       Impact factor: 1.568

Review 4.  Triggers of inflammatory myopathy: insights into pathogenesis.

Authors:  Brittany L Adler; Lisa Christopher-Stine
Journal:  Discov Med       Date:  2018-02       Impact factor: 2.970

Review 5.  Cutting edge issues in polymyositis.

Authors:  Anna Ghirardello; Sandra Zampieri; Elena Tarricone; Luca Iaccarino; Luisa Gorza; Andrea Doria
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 6.  Paraneoplastic syndromes in rheumatology.

Authors:  Bernhard Manger; Georg Schett
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

Review 7.  Polymyositis associated with hypothyroidism or hyperthyroidism: two cases and review of the literature.

Authors:  Han Wang; Hong Li; Cui Kai; Juelin Deng
Journal:  Clin Rheumatol       Date:  2010-09-21       Impact factor: 2.980

Review 8.  Malignancy in myositis.

Authors:  Zaki Abou Zahr; Alan N Baer
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

9.  Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation.

Authors:  Maurizio Vitadello; Andrea Doria; Elena Tarricone; Anna Ghirardello; Luisa Gorza
Journal:  Arthritis Res Ther       Date:  2010-03-24       Impact factor: 5.156

10.  Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.

Authors:  Paola Aulino; Emanuele Berardi; Veronica M Cardillo; Emanuele Rizzuto; Barbara Perniconi; Carla Ramina; Fabrizio Padula; Enrico P Spugnini; Alfonso Baldi; Fabio Faiola; Sergio Adamo; Dario Coletti
Journal:  BMC Cancer       Date:  2010-07-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.